Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Factor VIII"" wg kryterium: Temat


Tytuł :
Regulation and importance of factor VIII levels in hemophilia A carriers.
Autorzy :
Cygan PH; Division of Hematology/Oncology, Department of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania.
Kouides PA; University of Rochester School of Medicine and the Mary M. Gooley Hemophilia Center at Rochester General Hospital, Rochester, New York, USA.
Pokaż więcej
Źródło :
Current opinion in hematology [Curr Opin Hematol] 2021 Sep 01; Vol. 28 (5), pp. 315-322.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
MeSH Terms :
Factor VIII*/genetics
Factor VIII*/metabolism
Hemophilia A*/blood
Hemophilia A*/genetics
Hemorrhage*/blood
Hemorrhage*/genetics
Heterozygote*
Phenotype*
Chromosomes, Human, X/*genetics
Female ; Humans
Czasopismo naukowe
Tytuł :
FVIII inhibitors display FV-neutralizing activity in the prothrombin time assay.
Autorzy :
Arsiccio A; Department of Applied Science and Technology, Politecnico di Torino, Torino, Italy.
Beavis J; Oxford Haemophilia Centre, Churchill Hospital, Oxford, UK.
Raut S; National Institute for Biological Standards and Control, Potters Bar, UK.
Coxon CH; National Institute for Biological Standards and Control, Potters Bar, UK.
Pokaż więcej
Źródło :
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2021 Aug; Vol. 19 (8), pp. 1907-1913. Date of Electronic Publication: 2021 May 20.
Typ publikacji :
Journal Article
MeSH Terms :
Factor VIII*
Hemophilia A*/drug therapy
Blood Coagulation Tests ; Hemostasis ; Humans ; Prothrombin Time
Czasopismo naukowe
Tytuł :
Characteristics of Acquired Inhibitors to Factor VIII and Von Willebrand Factor Secondary to Systemic Lupus Erythematosus: Experiences From a Chinese Tertiary Medical Center.
Autorzy :
Cao XY; From the Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Graduate School of Peking Union Medical College, Beijing.
Li MT; From the Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Graduate School of Peking Union Medical College, Beijing.
Zhang X; From the Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Graduate School of Peking Union Medical College, Beijing.
Zhao Y; From the Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Graduate School of Peking Union Medical College, Beijing.
Zeng XF; From the Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Graduate School of Peking Union Medical College, Beijing.
Zhang FC; From the Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Graduate School of Peking Union Medical College, Beijing.
Hou Y; From the Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Graduate School of Peking Union Medical College, Beijing.
Zhu LX
Pokaż więcej
Źródło :
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases [J Clin Rheumatol] 2021 Aug 01; Vol. 27 (5), pp. 201-205.
Typ publikacji :
Journal Article
MeSH Terms :
Factor VIII*
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/diagnosis
von Willebrand Factor*
Hemophilia A/*etiology
Adult ; Antiphospholipid Syndrome/etiology ; China/epidemiology ; Female ; Hospitals ; Humans ; Middle Aged ; Young Adult
Czasopismo naukowe
Tytuł :
Pharmacokinetics and complementary evaluation system-based guidance on prophylaxis of paediatric patients with haemophilia A in China with Kovaltry: protocol of the LEAP study.
Autorzy :
Kun H; Hematology Center, Beijing Children's Hospital, Capital Medical University, Beijing, China.
Xu W; Department of Hematology and Oncology, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Pediatric Leukemia Diagnostic and Therapeutic Technology Research Center of Zhejiang Province, Zhejiang, China.
Zhou M; Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Li X; Department of Hematology, Chengdu Women & Children's New Century Hospital, Chengdu, China.
Xu Z; Department of Hematology, Jiangxi Provincial Children's Hospital, Nanchang, China.
Fang Y; Department of Hematology and Oncology, Children's Hospital of Nanjing Medical University School of Medicine, Nanjing, China.
Li C; Department of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Chen Z; Hematologic Disease Laboratory, Hematology Center, Beijing Children's Hospital, Capital Medical University, Beijing, China .
Wu R; Hematology Center, Beijing Children's Hospital, Capital Medical University, Beijing, China .
Pokaż więcej
Źródło :
BMJ open [BMJ Open] 2021 Jul 05; Vol. 11 (7), pp. e048432. Date of Electronic Publication: 2021 Jul 05.
Typ publikacji :
Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Factor VIII*/therapeutic use
Hemophilia A*/drug therapy
Child ; China ; Humans ; Prospective Studies
Czasopismo naukowe
Tytuł :
Perioperative pharmacokinetic-guided factor VIII concentrate dosing in haemophilia (OPTI-CLOT trial): an open-label, multicentre, randomised, controlled trial.
Autorzy :
van Moort I; Department of Pediatric Hematology, Erasmus MC Sophia Children's Hospital, Rotterdam, Netherlands.
Preijers T; Department of Clinical Pharmacology - Hospital Pharmacy, Amsterdam University Medical Centers, Amsterdam, Netherlands.
Bukkems LH; Department of Clinical Pharmacology - Hospital Pharmacy, Amsterdam University Medical Centers, Amsterdam, Netherlands.
Hazendonk HCAM; Department of Pediatric Hematology, Erasmus MC Sophia Children's Hospital, Rotterdam, Netherlands.
van der Bom JG; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands.
Laros-van Gorkom BAP; Department of Thrombosis and Hemostasis, Radboud University Medical Center Nijmegen, Nijmegen, Netherlands.
Beckers EAM; Department of Thrombosis and Hemostasis, Maastricht University Medical Center, Maastricht, Netherlands.
Nieuwenhuizen L; Department of Internal Medicine, Maxima Medical Center, Veldhoven, Netherlands.
van der Meer FJM; Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, Netherlands.
Ypma P; Department of Thrombosis and Hemostasis, Haga Hospital, The Hague, Netherlands.
Coppens M; Amsterdam UMC, University of Amsterdam, Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, Netherlands.
Fijnvandraat K; Amsterdam UMC, University of Amsterdam, Emma Children's Hospital, Pediatric Hematology, Amsterdam, Netherlands; Department of Molecular and Cellular Hemostasis, Sanquin Research, Amsterdam, Netherlands.
Schutgens REG; Van Creveldkliniek, University Medical Center Utrecht, Utrecht, Netherlands.
Meijer K; Department of Hematology, University Medical Center Groningen, Groningen, Netherlands.
Leebeek FWG; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Mathôt RAA; Department of Clinical Pharmacology - Hospital Pharmacy, Amsterdam University Medical Centers, Amsterdam, Netherlands.
Cnossen MH; Department of Pediatric Hematology, Erasmus MC Sophia Children's Hospital, Rotterdam, Netherlands. Electronic address: .
Pokaż więcej
Corporate Authors :
OPTI-CLOT study group
Źródło :
The Lancet. Haematology [Lancet Haematol] 2021 Jul; Vol. 8 (7), pp. e492-e502.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Coagulants/*therapeutic use
Factor VIII/*therapeutic use
Hemophilia A/*drug therapy
Adult ; Coagulants/pharmacokinetics ; Drug Administration Schedule ; Elective Surgical Procedures ; Factor VIII/pharmacokinetics ; Hemophilia A/pathology ; Humans ; Male ; Middle Aged ; Perioperative Care ; Severity of Illness Index ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Pharmacokinetic study of Kovaltry in thirty-five pediatric patients aged <12 years with severe hemophilia A.
Autorzy :
Huang K; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Ministry of Education, Beijing, China.
Zhen Y; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Ministry of Education, Beijing, China.
Li G; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Ministry of Education, Beijing, China.
Wu X; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Ministry of Education, Beijing, China.
Wu R; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Ministry of Education, Beijing, China.
Chen Z; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Ministry of Education, Beijing, China.
Pokaż więcej
Źródło :
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2021 May; Vol. 27 (3), pp. e340-e346. Date of Electronic Publication: 2021 Mar 01.
Typ publikacji :
Journal Article
MeSH Terms :
Factor VIII*/pharmacokinetics
Factor VIII*/therapeutic use
Hemophilia A*/drug therapy
Child ; Half-Life ; Humans ; Male ; von Willebrand Factor
Czasopismo naukowe
Tytuł :
Dr Judith Graham Pool and the development of cryoprecipitate.
Autorzy :
Swenson E; Department of Pathology, Stanford University School of Medicine, Palo Alto, California, USA.
Hollenhorst MA; Department of Pathology, Stanford University School of Medicine, Palo Alto, California, USA.; Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA.; Stanford Chemistry, Engineering, and Human Health Institute (ChEM-H), Palo Alto, California, USA.
Pokaż więcej
Źródło :
Transfusion [Transfusion] 2021 Jun; Vol. 61 (6), pp. 1676-1677. Date of Electronic Publication: 2021 Apr 24.
Typ publikacji :
Biography; Historical Article; Journal Article
MeSH Terms :
Factor VIII*/chemistry
Factor VIII*/therapeutic use
Fibrinogen*/chemistry
Fibrinogen*/therapeutic use
Biomedical Research ; Blood Coagulation ; Hemophilia A/blood ; Hemophilia A/therapy ; History, 20th Century ; Humans ; United States
Personal Name as Subject :
Pool J
Czasopismo naukowe
Tytuł :
Validation of factor VIII activity for monitoring standard and extended half-life products and correlation to thrombin generation assays.
Autorzy :
Augustsson C; Department of Clinical Chemistry and Pharmacology, Division of Laboratory Medicine, Coagulation, University and Regional Laboratories Region Skåne, Malmö, Sweden.
Norström E; Department of Translational Medicine, Lund University, Malmö, Sweden.
Lind V; Department of Clinical Chemistry and Pharmacology, Division of Laboratory Medicine, Coagulation, University and Regional Laboratories Region Skåne, Malmö, Sweden.
Martin M; Department of Clinical Chemistry and Pharmacology, Division of Laboratory Medicine, Coagulation, University and Regional Laboratories Region Skåne, Malmö, Sweden.
Astermark J; Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, and Department of Translational Medicine, Lund University, Malmö, Sweden.
Strandberg K; Department of Clinical Chemistry and Pharmacology, Division of Laboratory Medicine, Coagulation, University and Regional Laboratories Region Skåne, Malmö, Sweden.
Pokaż więcej
Źródło :
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2021 May; Vol. 27 (3), pp. 494-500. Date of Electronic Publication: 2021 Apr 18.
Typ publikacji :
Journal Article
MeSH Terms :
Factor VIII*/pharmacokinetics
Hemophilia A*/drug therapy
Blood Coagulation Tests ; Half-Life ; Humans ; Thrombin
Czasopismo naukowe
Tytuł :
Early Identification of Argatroban Resistance and the Consideration of Factor VIII.
Autorzy :
Poyant JO; Department of Pharmacy, 1867Tufts Medical Center, Boston, MA, USA.
Gleason AM; Department of Surgery, 1867Tufts Medical Center, Boston, MA, USA.
Pokaż więcej
Źródło :
Journal of pharmacy practice [J Pharm Pract] 2021 Apr; Vol. 34 (2), pp. 329-331. Date of Electronic Publication: 2019 Nov 06.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Factor VIII*
Percutaneous Coronary Intervention*
Aged ; Anticoagulants ; Arginine/analogs & derivatives ; Female ; Heparin ; Humans ; Pipecolic Acids ; Sulfonamides
Czasopismo naukowe
Tytuł :
Falsely decreased FVIII activity following pneumatic tube transport.
Autorzy :
Wang H; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; National Key Clinical Department of Laboratory Medicine, Nanjing, China.
Wang L; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; National Key Clinical Department of Laboratory Medicine, Nanjing, China.
Liang H; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; National Key Clinical Department of Laboratory Medicine, Nanjing, China.
Wei J; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Wu Y; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Wang X; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xu J; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; National Key Clinical Department of Laboratory Medicine, Nanjing, China.
Pokaż więcej
Źródło :
International journal of laboratory hematology [Int J Lab Hematol] 2021 Apr; Vol. 43 (2), pp. 305-310. Date of Electronic Publication: 2020 Oct 15.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Coagulation*
Factor VIII*/metabolism
Blood Coagulation Tests/*standards
Blood Specimen Collection/*methods
Blood Specimen Collection/*standards
Adult ; Blood Coagulation Tests/methods ; False Negative Reactions ; Female ; Hemolysis ; Humans ; Male ; Middle Aged ; Specimen Handling/adverse effects ; Specimen Handling/methods ; Young Adult
Czasopismo naukowe
Tytuł :
Deciphering the Ets-1/2-mediated transcriptional regulation of F8 gene identifies a minimal F8 promoter for hemophilia A gene therapy.
Autorzy :
Famà R; Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
Borroni E; Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
Merlin S; Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
Airoldi C; Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Pignani S; Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
Cucci A; Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
Corà D; Department of Translational Medicine, Center for Translational Research on Autoimmune and Allergic Disease (CAAD), University of Piemonte Orientale, Novara, Italy.
Bruscaggin V; Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
Scardellato S; Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
Faletti S; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Pelicci G; Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
Pinotti M; Department of Life Sciences and Biotechnology, Universita' di Ferrara, Italy.
Walker GE; Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
Follenzi A; Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
Pokaż więcej
Źródło :
Haematologica [Haematologica] 2021 Jun 01; Vol. 106 (6), pp. 1624-1635. Date of Electronic Publication: 2021 Jun 01.
Typ publikacji :
Journal Article
MeSH Terms :
Factor VIII*/genetics
Hemophilia A*/genetics
Hemophilia A*/therapy
Animals ; Endothelial Cells ; Genetic Therapy ; Lentivirus/genetics ; Mice
Czasopismo naukowe
Tytuł :
Dosing of factor VIII concentrate by ideal body weight is more accurate in overweight and obese haemophilia A patients.
Autorzy :
van Moort I; Department of Pediatric Hematology, Erasmus University Medical Center - Sophia Children's Hospital Rotterdam, The Netherlands.
Preijers T; Department of Clinical Pharmacology - Hospital Pharmacy, Amsterdam University Medical Centers, The Netherlands.
Hazendonk HCAM; Department of Pediatric Hematology, Erasmus University Medical Center - Sophia Children's Hospital Rotterdam, The Netherlands.
Schutgens REG; Van Creveldkliniek, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands.
Laros-van Gorkom BAP; Department of Thrombosis and Hemostasis, Radboud university medical center, Nijmegen, The Netherlands.
Nieuwenhuizen L; Department of Thrombosis and Hemostasis, Maxima Medical Center, Veldhoven, The Netherlands.
van der Meer FJM; Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.
Fijnvandraat K; Department of Pediatric Hematology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Department of Molecular and Cellular Hemostasis, Sanquin Research, Amsterdam, the Netherlands.
Leebeek FWG; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Meijer K; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
Mathôt RAA; Department of Clinical Pharmacology - Hospital Pharmacy, Amsterdam University Medical Centers, The Netherlands.
Cnossen MH; Department of Pediatric Hematology, Erasmus University Medical Center - Sophia Children's Hospital Rotterdam, The Netherlands.
Pokaż więcej
Corporate Authors :
OPTI-CLOT study group
Źródło :
British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Jun; Vol. 87 (6), pp. 2602-2613. Date of Electronic Publication: 2020 Dec 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Factor VIII*
Hemophilia A*/drug therapy
Adolescent ; Adult ; Aged ; Humans ; Ideal Body Weight ; Middle Aged ; Obesity/drug therapy ; Overweight/drug therapy ; Young Adult
Czasopismo naukowe
Tytuł :
Effects of pathogen reduction technology and storage duration on the ability of cryoprecipitate to rescue induced coagulopathies in vitro.
Autorzy :
Thomas KA; Department of Pediatrics, Division of Critical Care, Washington University School of Medicine, St. Louis, Missouri, USA.
Shea SM; Department of Pediatrics, Division of Critical Care, Washington University School of Medicine, St. Louis, Missouri, USA.
Spinella PC; Department of Pediatrics, Division of Critical Care, Washington University School of Medicine, St. Louis, Missouri, USA.
Pokaż więcej
Źródło :
Transfusion [Transfusion] 2021 Jun; Vol. 61 (6), pp. 1943-1954. Date of Electronic Publication: 2021 Mar 23.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Blood Safety*/methods
Hemostasis*/drug effects
Factor VIII/*pharmacology
Fibrinogen/*pharmacology
Hemostatics/*pharmacology
Blood Coagulation Disorders/blood ; Blood Coagulation Disorders/therapy ; Blood Coagulation Factors/analysis ; Blood Coagulation Factors/pharmacology ; Factor VIII/analysis ; Fibrinogen/analysis ; Hemostatics/analysis ; Humans ; Sterilization/methods
Czasopismo naukowe
Tytuł :
Confirmed long-term safety and efficacy of prophylactic treatment with BAY 94-9027 in severe haemophilia A: final results of the PROTECT VIII extension study.
Autorzy :
Reding MT; Center for Bleeding and Clotting Disorders, University of Minnesota Medical Center, Minneapolis, MN, USA.
Pabinger I; University Clinic for Internal Medicine I, Medical University of Vienna, Vienna, Austria.
Holme PA; Department of Haematology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Poulsen L; The Haemophilia Centre, Aarhus University Hospital, Aarhus, Denmark.
Negrier C; Hemophilia Comprehensive Care Center and Hematology Department, Louis Pradel University Hospital, Lyon, France.
Chalasani P; Division of Hematology and Oncology, University of Arizona Cancer Center, Phoenix, AZ, USA.
Maas Enriquez M; Bayer, Wuppertal, Germany.
Wang M; Bayer, Whippany, NJ, USA.
Meijer K; University Medical Center Groningen, Groningen, Netherlands.
Mancuso ME; Center for Thrombosis and Haemorrhagic Diseases, IRCCS Humanitas Clinical and Research Center, Rozzano, Italy.
Lalezari S; National Haemophilia Centre, Chaim Sheba Medical Centre, Tel Aviv University, Tel Hashomer, Israel.
Pokaż więcej
Źródło :
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2021 May; Vol. 27 (3), pp. e347-e356. Date of Electronic Publication: 2021 Apr 05.
Typ publikacji :
Clinical Trial; Journal Article; Multicenter Study
MeSH Terms :
Factor VIII*/therapeutic use
Hemophilia A*/drug therapy
Polyethylene Glycols*/therapeutic use
Humans ; Male ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Continuous infusion with octocog alfa during cardiac surgery for tetralogy of Fallot in a haemophilic child.
Autorzy :
Lassandro G; Paediatric Section, Department of Biomedicine and Human Oncology, 'A. Moro' University, Bari, Italy.
Scalzo G; Department of Paediatric Cardiac Surgery, 'Giovanni XXIII' Paediatric Hospital, Bari, Italy.
Palmieri VV; Paediatric Section, Department of Biomedicine and Human Oncology, 'A. Moro' University, Bari, Italy.
Vairo U; Department of Paediatric Cardiology, 'Giovanni XXIII' Paediatric Hospital, Bari, Italy.
Milella L; Department of Paediatry Anaesthesia and Reanimation, Cardiac Surgery Intensive Care, Operating Rooms, 'Giovanni XXIII' Paediatric Hospital, Bari, Italy.
Scrascia G; Department of Paediatric Cardiac Surgery, 'Giovanni XXIII' Paediatric Hospital, Bari, Italy.
Mancuso ME; Department of Internal Medicine and Dermatology, 'Angelo Bianchi Bonomi' Haemophilia and Thrombosis Centre, IRCCS Maggiore Hospital, 'Mangiagalli and Regina Elena' Foundation and University of Milan, Milan, Italy.
Giordano P; Paediatric Section, Department of Biomedicine and Human Oncology, 'A. Moro' University, Bari, Italy.
Pokaż więcej
Źródło :
Blood transfusion = Trasfusione del sangue [Blood Transfus] 2021 May; Vol. 19 (3), pp. 253-256. Date of Electronic Publication: 2020 Jun 04.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Factor VIII/*therapeutic use
Hemophilia A/*complications
Hemophilia A/*drug therapy
Tetralogy of Fallot/*complications
Tetralogy of Fallot/*surgery
Cardiac Surgical Procedures ; Factor VIII/administration & dosage ; Hemophilia A/blood ; Humans ; Infant ; Tetralogy of Fallot/blood ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Extending the post-thaw viability of cryoprecipitate.
Autorzy :
Thomson C; SA Pathology - Flinders Medical Centre and Royal Adelaide Hospital, South Australia, Australia.; Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Sobieraj-Teague M; SA Pathology - Flinders Medical Centre and Royal Adelaide Hospital, South Australia, Australia.; Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Scott D; SA Pathology - Flinders Medical Centre and Royal Adelaide Hospital, South Australia, Australia.; Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Duncan E; SA Pathology - Flinders Medical Centre and Royal Adelaide Hospital, South Australia, Australia.; Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Abraham S; SA Pathology - Flinders Medical Centre and Royal Adelaide Hospital, South Australia, Australia.; Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Roxby D; SA Pathology - Flinders Medical Centre and Royal Adelaide Hospital, South Australia, Australia.; Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Pokaż więcej
Źródło :
Transfusion [Transfusion] 2021 May; Vol. 61 (5), pp. 1578-1585. Date of Electronic Publication: 2021 Mar 17.
Typ publikacji :
Journal Article
MeSH Terms :
Factor VIII/*chemistry
Fibrinogen/*chemistry
Blood Preservation/methods ; Cryopreservation/methods ; Factor VIII/analysis ; Factor XIII/analysis ; Fibrinogen/analysis ; Humans ; Temperature ; Thrombelastography ; Time Factors ; von Willebrand Factor/analysis
Czasopismo naukowe
Tytuł :
Factor VIII/IX inhibitor testing practices in the United Kingdom: Results of a UKHCDO and UKNEQAS national survey.
Autorzy :
Batty P; The Royal London Hospital Haemophilia Centre, Barts and The London School of Medicine and Dentistry, QMUL, London, UK.
Riddell A; Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free Hospital, London, UK.
Kitchen S; UK NEQAS (Blood Coagulation), Sheffield, UK.
Sardo Infirri S; The Royal London Hospital Haemophilia Centre, Barts and The London School of Medicine and Dentistry, QMUL, London, UK.
Walker I; UK NEQAS (Blood Coagulation), Sheffield, UK.
Woods T; UK NEQAS (Blood Coagulation), Sheffield, UK.
Jennings I; UK NEQAS (Blood Coagulation), Sheffield, UK.
Hart DP; The Royal London Hospital Haemophilia Centre, Barts and The London School of Medicine and Dentistry, QMUL, London, UK.
Pokaż więcej
Źródło :
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2021 May; Vol. 27 (3), pp. 490-499. Date of Electronic Publication: 2021 Mar 02.
Typ publikacji :
Journal Article
MeSH Terms :
Factor VIII*
Hemophilia A*/diagnosis
Hemophilia A*/drug therapy
Blood Coagulation Factor Inhibitors ; Blood Coagulation Tests ; Humans ; United Kingdom
Czasopismo naukowe
Tytuł :
DDB1- and CUL4-associated factor 8 plays a critical role in spermatogenesis.
Autorzy :
Zhang X; Shanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine at Shanghai, Collaborative Innovation Center of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Xia Z; Shanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine at Shanghai, Collaborative Innovation Center of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Lv X; Key Laboratory of Laparoscopic Technology of Zhejiang Province, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China.
Li D; Shanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine at Shanghai, Collaborative Innovation Center of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Liu M; Shanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine at Shanghai, Collaborative Innovation Center of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Zhang R; Shanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine at Shanghai, Collaborative Innovation Center of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Ji T; Department of General Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China. .
Liu P; Shanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine at Shanghai, Collaborative Innovation Center of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. .
Ren R; Shanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine at Shanghai, Collaborative Innovation Center of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. .
Pokaż więcej
Źródło :
Frontiers of medicine [Front Med] 2021 Apr; Vol. 15 (2), pp. 302-312. Date of Electronic Publication: 2021 Apr 14.
Typ publikacji :
Journal Article
MeSH Terms :
Factor VIII*
Spermatogenesis*/genetics
Animals ; Cullin Proteins/genetics ; DNA-Binding Proteins/genetics ; Male ; Mice ; Mice, Knockout ; Ubiquitin-Protein Ligases
Czasopismo naukowe
Tytuł :
Hepatitis E virus: Efficacy of pasteurization of plasma-derived VWF/FVIII concentrate determined by pig bioassay.
Autorzy :
Dähnert L; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Greifswald, Germany.
Schlosser J; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Greifswald, Germany.; Department of Veterinary Medicine, Freie Universität Berlin, Institute of Immunology, Berlin, Germany.
Fast C; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Greifswald, Germany.
Fröhlich A; Institute of Epidemiology, Friedrich-Loeffler-Institut, Greifswald, Germany.
Gröner A; PathoGuard Consult, Seeheim-Jugenheim, Germany.
Lange E; Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler-Institut, Greifswald, Germany.
Roth NJ; Global Pathogen Safety, CSL Behring AG, Bern, Switzerland.
Schäfer W; Global Pathogen Safety, CSL Behring GmbH, Marburg, Germany.
Schröder C; Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler-Institut, Greifswald, Germany.
Eiden M; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Greifswald, Germany.
Groschup MH; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Greifswald, Germany.
Pokaż więcej
Źródło :
Transfusion [Transfusion] 2021 Apr; Vol. 61 (4), pp. 1266-1277. Date of Electronic Publication: 2021 Feb 19.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Blood Component Transfusion/*adverse effects
Factor VIII/*administration & dosage
Hepatitis E/*etiology
Hepatitis E virus/*genetics
Pasteurization/*methods
von Willebrand Factor/*administration & dosage
Acute Disease ; Animals ; Biological Assay/methods ; Factor VIII/analysis ; Female ; Heating/adverse effects ; Hepatitis/epidemiology ; Hepatitis/virology ; Hepatitis E/prevention & control ; Male ; Models, Animal ; Safety ; Swine ; Time Factors ; Virus Inactivation ; Virus Replication/genetics ; von Willebrand Factor/analysis
Czasopismo naukowe
Tytuł :
Editorial: Tolerating Factor VIII: Novel Strategies to Prevent and Reverse Neutralizing Anti-FVIII Antibodies.
Autorzy :
Lacroix-Desmazes S; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.
Pratt KP; Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Jan 25; Vol. 11, pp. 639386. Date of Electronic Publication: 2021 Jan 25 (Print Publication: 2020).
Typ publikacji :
Editorial; Introductory Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Factor VIII*/adverse effects
Factor VIII*/immunology
Factor VIII*/therapeutic use
Hemophilia A*/drug therapy
Hemophilia A*/immunology
Immune Tolerance*
Antibodies, Neutralizing/*immunology
Blood Coagulation Factor Inhibitors/*immunology
Humans
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies